key: cord-0935960-l1y41310
authors: Li, Wei; Fu, Manli; Qian, Chao; Liu, Xin; Zeng, Lingkong; Peng, Xuehua; Hong, Yue; Zhou, Huan; Yuan, Li
title: Quantitative assessment of COVID‐19 pneumonia in neonates using lung ultrasound score
date: 2021-03-13
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.25325
sha: d213167f6d14005b3edda28d4a91cc1791a31d8c
doc_id: 935960
cord_uid: l1y41310

BACKGROUND: Lung ultrasound (LUS) and lung ultrasound score (LUSS) have been successfully used to diagnose neonatal pneumonia, assess the lesion distribution, and quantify the aeration loss. The present study design determines the diagnostic value of LUSS in the semi‐quantitative assessment of pneumonia in coronavirus disease 2019 (COVID‐19) neonates. METHODS: Eleven COVID‐19 neonates born to mothers with COVID‐19 infection and 11 age‐ and gender‐matched controls were retrospectively studied. LUSS was acquired by assessing the lesions and aeration loss in 12 lung regions per subject. RESULTS: Most of the COVID‐19 newborns presented with mild and atypical symptoms, mainly involving respiratory and digestive systems. In the COVID‐19 group, a total of 132 regions of the lung were examined, 83 regions (62.8%) of which were detected abnormalities by LUS. Compared with controls, COVID‐19 neonates showed sparse or confluent B‐lines (83 regions), disappearing A‐lines (83 regions), abnormal pleural lines (29 regions), and subpleural consolidations (2 regions). The LUSS was significantly higher in the COVID‐19 group. In total, 49 regions (37%) were normal, 73 regions (55%) scored 1, and 10 regions (8%) scored 2 by LUSS. All the lesions were bilateral, with multiple regions involved. The majority of the lesions were located in the bilateral inferior and posterior regions. LUS detected abnormalities in three COVID‐19 neonates with normal radiological performance. The intra‐observer and inter‐observer reproducibility of LUSS was excellent. CONCLUSIONS: LUS is a noninvasive, convenient, and sensitive method to assess neonatal COVID‐19 pneumonia, and can be used as an alternative to the use of diagnostic radiography. LUSS provides valuable semi‐quantitative information on the lesion distribution and severity.

The outbreak of coronavirus disease 2019 (COVID-19) has become a pandemic and is severely affecting public health worldwide. The epidemic is geographically focused in the city of Wuhan, Hubei, mainland China from January to March 2020. As increasing of new infections in Wuhan, the number of pregnant women with had been on the rise. The neonates born to mothers with COVID-19

were quarantined immediately after birth, some of whom were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive and developed COVID-19 pneumonia. 1 Chest computed tomography (CT) scan is an important diagnostic tool for COVID -19, with specific imaging findings in the pediatric population. 2 However, radiation safety concern for the neonates is essential.

Lung ultrasound (LUS) examination is convenient, nonionizing, and widely used in the assessment or monitoring of patients with infective pneumonia and dyspnea. COVID-19 lung lesions in children begin from and are mainly located in the peripheral thoracic area, and most pediatric patients are in the early stage of the disease.

Therefore, LUS has the advantage of detecting COVID-19 pneumonia lesions, and especially becomes essential for COVID-19 neonates.

A lung ultrasound score (LUSS) 3 is helpful to semi-quantitatively evaluate regional lung aeration, and has been successfully used in various pulmonary disease assessments.

The morbidity of COVID-19 in the pediatric population was low.

Our hospital was the exclusive children's hospital in Wuhan for treating COVID-19. Data regarding the lung lesion distribution and aeration loss of COVID-19 neonates using LUS are rare. Therefore, the present study aimed to investigate the ultrasonic features, lung lesion distribution, the severity of aeration loss of neonatal COVID-19 pneumonia using semi-quantitative LUSS method. Lung aeration loss can be estimated using a validated score called the Lung Ultrasound Score. As previously recommended, 3 the chest wall was divided into 12 regions (6 regions per hemithorax, A semi-quantitative LUSS was proposed for identifying four progressive stages of lung aeration loss, assigning a score from 0 to 3. See Table 1 and Figure 2 for a detailed description of LUSS. LUSS was independently assessed by two experienced reviewers for inter-observer reproducibility. Intra-observer analysis was performed using the recorded loops 4 weeks after the initial reading was conducted. The inter-and intra-observer reproducibility of LUSS was assessed using Bland-Altman plot, coefficient of variation, Pearson's correlation, and intra-class correlation coefficient (ICC). The coefficient of variation was defined as the standard deviation of differences between two readings in the percentage of the mean. p < .05 were considered statistically significant.

Demographic characteristics and clinical features of the COVID-19 group and control group were described in Table 2 . There were no differences in demographic characteristics between the two groups.

In the COVID-19 group, two babies born preterm and nine babies born at term. Most of the neonates initially experienced atypical and mild symptoms, that is, shortness of breath, vomiting, bucking, and lethargy. Two babies showed low-grade fever, with the others normal. There were two asymptomatic newborns. Radiographic findings commonly showed peripheral ground-glass opacities (GGO) and group were 29.5 ± 27.7 AU/ml and 73.9 ± 31.7 AU/ml, respectively.

In the COVID-19 group, there were a total of 132 regions 

Bland-Alterman plot revealed that the LUSS derived by two readings from intra-and inter-observers, were highly consistent ( Figure 4 ).

Both the intra-and inter-observer reproducibility were excellent, with ICCs of 0.930 and 0.854, respectively. Intra-observer reproducibility of LUSS slightly better than that of inter-observer (Table 4) . When confluent B-lines spread throughout the lung field, the ultrasound shows a compact B-line pattern representing severe pulmonary edema, which was not observed in our study due to mildly symptomatic neonatal patients. 15 LUS shows a high sensitivity and specificity to detect lung edema throughout B-line appearance, however, it is challenging to identify the etiology of edema, that is, cardiogenic, nephrogenic, or pneumonia. 16 We propose that it could be combined with other clinical and ultrasonic assessments to give a comprehensive judgment of the situation. Subpleural consolidation is another typical sign in neonatal COVID-19. It indicates that the lung tissue becomes T A B L E 3 Comparison of regional lung ultrasound score between the COVID-19 group and the control group regarding LUS application in the COVID-19 pediatric population, when compared with the gold standard of chest CT, chest X-ray displays falsenegative results for pulmonary involvement in 75%, whereas for LUS it is 16.7%. 10 Furthermore, LUS findings are more sensitive than chest Xray in pediatric patients with COVID-19 infection, especially in the early stage of the disease and in mild cases. 17 Since LUS detects the artifacts generated by the accumulation of fluid, we could rank the artifacts according to the air/liquid ratio and create a score reflecting lung aeration. LUSS, a three-stage classification system, could comprehensively and semi-quantitatively reflect the lung aeration function and disease severity. LUSS is well correlated with indices of oxygenation in both term and preterm neonates, 18 guiding surfactant therapy and weaning ventilator support. 19 LUSS could assess global and regional lung aeration, and well correlated with CT quantitative analysis indices 20 in ARDS. In the present study, the global LUSS was obviously higher in the COVID-19 group, in consistent with patients' symptoms. Patients with two lowest scores were asymptomatic. Two patients, in whom regions scored 2 were more than three regions, presented with obvious shortness of breath and digestive symptoms, along with positive chest radiographic findings. The regional score also reflected variant loss of lung aeration and severity of infectious lesions, especially in bilateral inferior and posterior regions. LUSS calculation shows a high intra-and inter-observer agreement regardless of the observer's experience, 18 which has also been validated in our study.

One limitation of the study was the small sample size due to low morbidity in neonates and control of epidemics in Wuhan. The other limitation was the retrospective study, and few positive cases were not enrolled due to lack of timely LUS examination. However, the missing cases were fundamentally with mild clinical course, and the study was representative.

In the present study, we presented the typical ultrasonic features of neonatal COVID-19 pneumonia using a bedside ultrasound machine.

LUSS, with excellent intra-observer and inter-observer reproducibility, can semi-quantitatively assess global and regional lung aeration and disease severity. LUS findings are in accordance with clinical symptoms and radiographic manifestations. In clinic settings, we should keep in mind that combining the imaging findings with clinic, epidemiological, and etiological evidence to diagnose COVID-19. However, LUS is a free radiational, convenient, noninvasive, reproducible, and reliable imaging modality, and can be used as an alternative to the use of diagnostic radiography in neonatal COVID-19 pneumonia diagnosis and monitoring. 

Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China

A single-center, retrospective study of COVID-19 features in children: a descriptive investigation

Modified lung ultrasound score for assessing and monitoring pulmonary aeration

Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection

Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features

SARS-CoV-2 infection in children

Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults

Diagnostic value of lung ultrasonography in children with COVID-19

Lung ultrasound in the critically ill neonate

Prospective evaluation of point-ofcare ultrasonography for the diagnosis of pneumonia in children and young adults

Feasibility and safety of substituting lung ultrasonography for chest radiography when diagnosing pneumonia in children: a randomized controlled trial

Lung ultrasound decreased radiation exposure in preterm infants in a neonatal intensive care unit

Can neonatal lung ultrasound monitor fluid clearance and predict the need of respiratory support?

Lung B-line artefacts and their use

Point-of-care lung ultrasound findings in the pediatric emergency clinic during the COVID-19 pandemic

Lung ultrasonography score to evaluate oxygenation and surfactant need in neonates treated with continuous positive airway pressure

Value of lung ultrasonography to predict weaning success in ventilated neonates

Assessment of lung aeration and recruitment by CT scan and ultrasound in acute respiratory distress syndrome patients

The authors declare that there are no conflict of interests.

Wei Li, Manli Fu, and Li Yuan contributed to the study design, analysis, interpretation of the results, and draft of the manuscript. Chao Qian and Yue Hong contributed to the ultrasound image reading and scoring. Lingkong Zeng, Huan Zhou, and Xin Liu contributed to the data collection, analysis, and interpretation of the results. Xuehua Peng contributed to the radiographic reading and interpretation of the results. All authors critically revised the manuscript and approved the final version.

The data that support the findings of this study titled "Quantitative assessment of COVID-19 pneumonia in neonates using lung ultrasound score" are available from the corresponding author upon reasonable request.

http://orcid.org/0000-0003-1299-5263